Frequent occult infection with cytomegalovirus despite antiviral prophylaxis in cardiac transplant recipients

Department of Medicine and Microbiology & Immunology, Stanford University School of Medicine, Stanford, California; Department of Microbiology & Immunology, Emory University School of Medicine, Atlanta, Georgia

^* To whom correspondence should be addressed. Email: mocarski{at}emory.edu.

	Abstract

Despite antiviral prophylaxis, a high percentage (over 90%) of heart transplant patients experience active cytomegalovirus (CMV) infection diagnosed by detection of viral DNA in peripheral blood polymorphonuclear leukocytes within the first few months post transplantation. Viral DNA was detected in mononuclear cells prior to detection in granulocytes from CMV-seropositive recipients (R+) receiving a heart from a CMV-seropositive donor (D+). Based on assessment of systemic infection in leukocyte populations, both R+ subgroups (R+/D- and R+/D+) experienced a greater infection burden than the R-/D+ subgroup, which was aggressively prophylaxed because of a higher risk of CMV acute disease. Despite widespread systemic infection in all at-risk patient subgroups, CMV DNA was rarely (<3% of patients) detected in transplanted heart biopsy specimens. The R+ patients more frequently exceeded the 75^th percentile of the CMV DNA copy number distribution in leukocytes (110 copies/10⁵ PMNs) than the R-/D+ subgroup. Therefore, active systemic CMV infection involving leukocytes is common in heart transplant recipients despite prophylaxis at levels that reduce acute disease. Infection of the transplanted organ is rare, suggesting that chronic vascular disease attributed to CMV may be driven by the consequences of systemic infection.